Clinical Trial

Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital

Recruiting
View on ClinicalTrials.gov →
Summary
The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-27
Trial Details
NCT Number NCT07591701
Lead Sponsor M.D. Anderson Cancer Center
Conditions Prostate Cancer
Enrollment 60 participants
Start Date 2026-05-26
Primary Completion 2028-01-31 (estimated)
Study Completion 2030-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-26